# LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

> **NCT05663125** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Recurrent Glioblastoma

## Interventions

- **PROCEDURE:** Laser interstitial thermal therapy
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT05663125
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-12-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663125, "LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05663125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*